Haloperidol-induced catalepsy is influenced by adenosine receptor antagonists

Polish Journal of Pharmacology

Volumn 49, Issue 5, 1997, Pages 323-327

  Malec, Danuta ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

3,7 Dimethyl 1 propargylxanthine; 8 Cyclopentyltheophylline; Catalepsy; Haloperidfol; Methylxanthines

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE; HALOPERIDOL; THEOPHYLLINE;

ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

ANIMALS; CAFFEINE; CATALEPSY; DOPAMINE ANTAGONISTS; HALOPERIDOL; MALE; PURINERGIC P1 RECEPTOR ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; THEOBROMINE; THEOPHYLLINE;

EID: 0030838317     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. 2a receptors in the nucleus accumbens mediate locomotor depression. Brain Res. Bull., 1993, 31, 397-404.
2. 2a purine receptors regulate striatal acetylcholine release. J. Neurochem., 1990, 55, 31-38.
3. Casas M., Ferre S., Guix T., Jane F.: Theophylline reverses haloperidol-induced catalepsy in the rat. Possible relevance to the pharmacological treatment of psychosis. Biol. Psychiat., 1988, 24, 642-648.
4. Costall B., Olley J. E.: Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen. Neuropharmacology, 1971, 10, 297-306.
5. Dijk S., Krugers H. J., Korf J.: The effect of theophylline and immobilization stress on haloperidol-induced catalepsy and on metabolism in the striatum and hippocampus, studied with lactography. Neuropharmacology, 1991, 30, 469-473.
6. 2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxy-dopamine-lesioned rats. Eur. J. Pharmacol., 1997, 321, 143-147.
7. Ferre S., Fuxe K., Von Euler G., Johansson B., Fredholm B. B.: Adenosine - dopamine interactions in the brain. Neuroscience, 1992, 51, 501-512.
8. Ferre S., O'Connor W., Fuxe K., Ungerstedt U.: The striopallidal neuron: a main locus for adenosine - dopamine interactions in the brain. J. Neurosci., 1993, 13, 5402-5406.
9. 2 receptors induces catalepsy. Neurosci. Lett., 1991, 130, 162-164.
10. 3H]-cyclohexyladenosine. J. Neurosci., 1982, 2, 1230-1241.
11. 2A receptors in the nucleus accumbens and the caudate-putamen. Eur. J. Pharmacol., 1997, 323, 127-131.
12. 3H]-CGS 21680. Eur. J. Pharmacol., 1989, 168, 243-246.
13. 2A receptor antagonist with anticataleptic activity. Eur. J. Pharmacol., 1994, 256, 263-268.
14. Londos C., Cooper D. M. F., Wolff J.: Subclasses of external adenosine receptors. Proc. Nat. Acad. Sci. USA, 1980, 77, 2551-2554.
15. 2 receptor interaction in globus pallidus. Synapse, 1996, 22, 132-138.
16. 1 receptors. Brain Res. Bull., 1991, 27, 101-104.
17. Okada M., Kiryu K., Kawata Y., Mizuno K., Wada K., Tasaki H., Kaneko S.: Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur. J. Pharmacol., 1997, 321, 181-188.
18. Okada M., Mizuno K., Okuyama M., Kaneko S.: Magnesium ion augmentation of inhibitory effects of adenosine on dopamine release in the rat striatum. Psychiatry Clin. Neurosci., 1996, 50, 147
19. Ossowska K., Wȩdzony K., Wolfarth S.: The role of the GABA mechanisms of the globus pallidus in mediating catalepsy, stereotypy and locomotor activity. Pharmacol. Biochem. Behav., 1984, 21, 825-831.
20. 1 agonists in dopamine-denervated rats. Eur. J. Neurosci., 1996, 8, 1176-1181.
21. Reddington M., Lee K. S.: Adenosine receptor subtypes: classification and distribution. In: Adenosine in the Nervous System. Ed. Stone T. W., Academic Press, London, 1991, 77-102.
22. Sanberg P. R.: Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature, 1980, 284, 472-473.
23. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemical study. J. Neurochem., 1991, 57, 1062-1067.
24. Simon P., Langwiński R., Boissier J. R.: Comparaison de différents tests d'évaluation de la catalepsie chez le rat. Thérapie, 1969, 24, 985-995.
25. Van Calker D., Miller M., Hamprecht B.: Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem., 1979, 33, 999-1005.
26. Williams M.: Adenosine : the prototypic neuromodulator. Neurochem. Int., 1989, 14, 249-264.
27. Zetterström T., Fillenz M.: Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release. Eur. J. Pharmacol., 1990, 180, 137-143.